Journal of Medicinal Chemistry
Volume 41, Issue 8 (April 9, 1998)
Copyright © 1998 American Chemical Society

Click [Full Article - PDF] to display or print the full article page image in PDF.

COMMUNICATIONS TO THE EDITOR

1205-1208

4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]- piperazinyl]-6,7-dimethoxyquinazoline (L-765,314): A Potent and Selective 1b Adrenergic Receptor Antagonist Michael A. Patane, Ann L. Scott, Theodore P. Broten, Raymond S. L. Chang, Richard W. Ransom, Jerry DiSalvo, Carlos Forray, and Mark G. Bock [Full Article - PDF]

ARTICLES

1209-1217

Inhibition of Membrane-Type 1 Matrix Metalloproteinase by Hydroxamate Inhibitors: An Examination of the Subsite Pocket Minoru Yamamoto, Hideki Tsujishita, Noriyuki Hori, Yuichi Ohishi, Shintaro Inoue, Shoji Ikeda, and Yasunori Okada [Full Article - PDF]

1218-1235

The Selective 5-HT1B Receptor Inverse Agonist 1'-Methyl-5-[[2'-methyl-4'- (5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) Potently Blocks Terminal 5-HT Autoreceptor Function Both in Vitro and in Vivo Laramie M. Gaster, Frank E. Blaney, Susannah Davies, D. Malcolm Duckworth, Peter Ham, Sarah Jenkins, Andrew J. Jennings, Graham F. Joiner, Frank D. King, Keith R. Mulholland, Paul A. Wyman, Jim J. Hagan, Jon Hatcher, Brian J. Jones, Derek N. Middlemiss, Gary W. Price, Graham Riley, Claire Roberts, Carol Routledge, Julie Selkirk, and Paula D. Slade [Full Article - PDF]

1236-1241

Synthesis and Antiviral Evaluation of Certain Novel Pyrazinoic Acid C-Nucleosides John A. Walker, II, Weimin Liu, Dean S. Wise, John C. Drach, and Leroy B. Townsend [Full Article - PDF]

1242-1251

Design, Synthesis, and Antiviral Activity of -Nucleosides: D- and L-Isomers of Lyxofuranosyl- and (5-Deoxylyxofuranosyl)benzimidazoles Michael T. Migawa, Jean-Luc Girardet, John A. Walker II, George W. Koszalka, Stanley D. Chamberlain, John C. Drach, and Leroy B. Townsend* [Full Article - PDF]

1252-1262

Design, Synthesis, and Antiviral Evaluations of 1-(Substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as Nonnucleoside Analogues of 2,5,6-Trichloro-1-(-D-ribofuranosyl)benzimidazole Anthony R. Porcari, Rodrigo V. Devivar, Louis S. Kucera, John C. Drach, and Leroy B. Townsend [Full Article - PDF]

1263-1271

Selective Pneumocystis carinii Dihydrofolate Reductase Inhibitors: Design, Synthesis, and Biological Evaluation of New 2,4-Diamino-5-substituted-furo[2,3-d]pyrimidines Aleem Gangjee, Xin Guo, Sherry F. Queener, Vivian Cody, Nikolai Galitsky, Joe R. Luft, and Walter Pangborn [Full Article - PDF]

1272-1283

Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues: Highly Potent Selective Estrogen Receptor Modulators Timothy A. Grese, Lewis D. Pennington, James P. Sluka, M. Dee Adrian, Harlan W. Cole, Tina R. Fuson, David E. Magee, D. Lynn Phillips, Ellen R. Rowley, Pamela K. Shetler, Lorri L. Short, Murali Venugopalan, Na N. Yang, Masahiko Sato, Andrew L. Glasebrook, and Henry U. Bryant [Full Article - PDF]

1284-1298

Synthesis and Antiviral Activity of Novel Acyclic Nucleosides: Discovery of a Cyclopropyl Nucleoside with Potent Inhibitory Activity against Herpesviruses Takaaki Sekiyama, Satoshi Hatsuya, Yasuhiro Tanaka, Mamoru Uchiyama, Nobukazu Ono, Satoshi Iwayama, Miki Oikawa, Katsuya Suzuki, Masahiko Okunishi, and Takashi Tsuji [Full Article - PDF]

1299-1305

d-Fused [1]Benzazepines with Selective in Vitro Antitumor Activity: Synthesis and Structure-Activity Relationships Andreas Link and Conrad Kunick [Full Article - PDF]

1306-1314

Epidoxoform: A Hydrolytically More Stable Anthracycline-Formaldehyde Conjugate Toxic to Resistant Tumor Cells Dylan J. Taatjes, David J. Fenick, and Tad H. Koch [Full Article - PDF]

1315-1343

Structure-Activity Studies on Anticonvulsant Sugar Sulfamates Related to Topiramate. Enhanced Potency with Cyclic Sulfate Derivatives Bruce E. Maryanoff, Michael J. Costanzo, Samuel O. Nortey, Michael N. Greco, Richard P. Shank, James J. Schupsky, Marta P. Ortegon, and Jeffry L. Vaught [Full Article - PDF]

1344-1351

Azapeptides as Inhibitors and Active Site Titrants for Cysteine Proteinases Ruye Xing and Robert P. Hanzlik [Full Article - PDF]

BOOK REVIEWS

1352-1353

Protein Structure: A Practical Approach Edited by T. E. Creighton, Editor. IRL Press, New York. 1997. xxiii + 383 pp. 15.5 x 23.5 cm. ISBN 0-19-963618-4. $55.00 (pbk). Protein Function: A Practical Approach Edited by T. E. Creighton, Editor. IRL Press, New York. 1997. xxi + 334 pp. 15.5 x 23.5 cm. ISBN 0-19-963615-4. $55.00 (pbk). R. Michael Garavito [Full Article - PDF]

1353-1353

Guanidino Compounds in Biology and Medicine: 2 Edited by P. De Deyn, B. Mareseau, I. A. Quneshi, and A. Mori. John Libbey & Company Limited, London. 1997. 405 pp. 19.5 × 24.5 cm. ISBN 0-81696-543-4. 66.00. Graham J. Durant [Full Article - PDF]

1353-1354

Antiviral Chemotherapy By Richard Challand and Robert J. Young. In Biochemical and Medicinal Chemistry Series. Series Editor John Mann. Spektrum Academic Publishers, Oxford, and University Science Books, Sausolito. 1997. viii + 128 pp. 19 × 24.5 cm. ISBN 1-901217-03-5. $28.50 (pbk). Nicholas A. Meanwell [Full Article - PDF]

1354-1354

Introduction to Medicinal Chemistry: How Drugs Act and Why Alex Gringauz. Wiley-VCH, Inc., New York. 1997. xiii + 721 pp. 18.5 × 26 cm. ISBN 0-471-18545-0. $89.95. Manfred E. Wolff [Full Article - PDF]

1354-1355

Annual Reports in Combinatorial Chemistry and Molecule Diversity, Volume 1 Edited by Walter H. Moos, Michael R. Pavia, Andrew D. Ellington, and Brian K. Kay. ESCOM Publishers, Leiden, The Netherlands. 1997. xiii + 354 pp. 17 × 24.5 cm. ISBN 90-72199-23.5. $97.00. Stephen R. Wilson [Full Article - PDF]

1355-1356

Purinergic Approaches in Experimental Therapeutics Edited by Kenneth A. Jacobson and Michael F. Jarvis. Wiley-Liss, New York. 1997. xiv + 581 pp. 16 × 24 cm. ISBN 0-47114071-6. $89.95. Shripad S. Bhagwat [Full Article - PDF]